Δευτέρα, 19 Μαρτίου 2012

Canadian researchers receive grant to test stem-cell therapy for septic shock

OTTAWA — A team of Canadian researchers has been awarded $442,000 to test the world's first experimental stem-cell therapy aimed at patients who suffer from septic shock, a runaway infection of the bloodstream that's notoriously difficult to treat.
The federal grant will allow researchers from theOttawa Hospital Research Institute to use mesenchymal stem cells, found in the bone marrow of healthy adults, to treat as many as 15 patients with septic shock.
The deadly infection occurs when toxic bacteria spreads rapidly throughout the body and over-activates the immune system, leading to multiple organ failure and death in up to 40 per cent of cases.

0 σχόλια:

Δημοσίευση σχολίου